Thus, altered intracellular Na+ and Ca2+ resulting from pH-regulated NHE1 activation (see reviews [4, 5]) may be an important contributor to cardiac arrhythmias following cardiac ischemia and that blocking NHE1 could be effective in attenuating ischemia-induced cardiac arrhythmias. Here, SLC9A1 is linked to cardiac rhythm disease.